| 33.82 Data as of Jun 19 |  -0.83 / -2.40%Today’s Change | 24.17 Today|||52-Week Range 35.96 | +13.76% Year-to-Date |
| 1 Reason Cantel Medical May Be Headed for a Slowdown Jun 17 / MotleyFool.com |
| Previous close | 34.65 |
| Today’s open | 34.68 |
| Day’s range | -- - -- |
| Volume | 53,254 |
| Average volume (3 months) | 84,471 |
| Market cap | $948.8M |
| Dividend yield | 0.33% |
| Earnings growth (last year) | +43.75% |
| Earnings growth (this year) | +20.87% |
| Earnings growth (next 5 years) | +18.00% |
| Revenue growth (last year) | +20.16% |
| P/E ratio | 24.0 |
| Price/Sales | 1.78 |
| Price/Book | 3.40 |
| Today’s change | Today’s % change | |
|---|---|---|
| PCRXPacira Pharmaceutica... | +0.14 | +0.47% |
| CNMDConmed Corp | -0.54 | -1.69% |
| SPNCSpectranetics Corp | -0.36 | -1.98% |
| MDXGMiMedx Group Inc | +0.00 | +0.07% |
| Last reporting date | June 6, 2013 |
| EPS forecast (this quarter) | $0.33 |
| Annual revenue (last year) | $386.5M |
| Annual profit (last year) | $30.8M |
| Net profit margin | 7.96% |
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Andrew A. Krakauer, MBA |
Chief Operating Officer & Executive Vice President Jorgen B. Hansen |
Corporate headquarters Little Falls, New Jersey |
.
